J Korean Soc Biol Psychiatry.
1999 Jul;6(1):34-40.
Beyond the SSRIs
Abstract
- New antidepressants have become available for clinical use in the 1990s. Before this decade, the drugs available to treat depression consisted essentially of monoamine oxidase inhibitors, tricyclic antidepressants, and lithium. Following the introduction of SSRIs, the options have expanded and now include SSRIs nefazodone, venlafaxine, mirtazapine, reboxetine, tianeptine. Newer antidepressants possess a variety of pharmacological characteristics that are relevant to the choice of an antidepressant for clinical use. This review summarizes some of the major pharmacological characteristics among the drugs.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Usefulness of LDAEP to Predict Tolerability to SSRIs in Major Depressive Disorder: A Case Report
- Do SSRIs Really Induce Suicidal Behavior? : The Critical Review of Evidences
- Treatment Strategy for Antidepressant-Resistant Depression in Korea: A Survey of Clinicians
- Comparison of Effect of SSRIs, SNRIs, and NaSSA on Pain
- Understanding and Treatment of Premenstrual Dysphoric Disorder
